Who Paid My Doc
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Eval
Research payments
$4,334,127
Through program year 2025, $4,334,127 in research payments was reported against A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Eval, across 950 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,951,168 | 707 |
| 2024 | Research | $1,382,960 | 243 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lee Clore Owensboro, KY Named on 61 payments
- Eduardo Martinez South Miami, FL Named on 53 payments
- Mustafa Naeem Tomball, TX Named on 50 payments
- Vikas Sayal Las Vegas, NV Named on 48 payments
- Mark Vandewalker Columbia, MO Named on 43 payments
- David Wheeler Philadelphia, PA Named on 40 payments
- Asisat Ope Jersey City, NJ Named on 35 payments
- Ramsey Joudeh Brooklyn, NY Named on 30 payments
- Michael Palumbo Washington, PA Named on 26 payments
- Henry Youga Dublin, OH Named on 26 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.